About Kausikh
Kausikh is a Healthcare company based in Chennai (India) founded in 2000 by Kausic Neelakantan. It manufactures pharmaceutical formulations, dosage forms, and offers contract research for global clients. It operates on a B2B and Contract Manufacturing model. The company has 161 employees. Its Indian entity Kausikh Therapeutics Private Limited reported revenue of βΉ60.69 Cr. Kausikh offers products and services including Tablets, Capsules, Liquid Orals, Oral Suspension, and Sachet. Its focus areas include Pharmaceuticals, Formulations, Dosage Forms and R&D Services. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Kausikh Therapeutics, established in 2000, is a privately held company focused on producing pharmaceutical formulations in Chennai, India. It operates state-of-the-art plants adhering to cGMP guidelines, manufacturing a wide range of dosage forms like tablets and capsules. The company emphasizes contract research, customer-oriented manufacturing, and global market supply, serving clients with various product specifications and regulatory compliance.
- Headquarters Chennai, India
- Employees 161
- Founders Kausic Neelakantan
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website kausikh.co.in
- Legal Name Kausikh Therapeutics Private Limited
- Date of Incorporation 19 Apr, 2000
- Jurisdiction Gerugambakkam, Tamil Nadu, India
- Annual Revenue₹60.69 Cr
FY 2025 · +8% YoY
- Net Profit₹53.3 Lakh
FY 2025 · 1% margin
- EBITDA₹4.17 Cr
FY 2025 · 7% margin
- Employee Count161
Associated legal entities of Kausikh
Kausikh operates through Kausikh Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kausikh Therapeutics Private Limited CIN U24232TN2000PTC044776 | Active | 19 Apr 2000 | Gerugambakkam, Tamil Nadu | ₹60.7 Cr | 161 | 3 | View details |
Products & Services of Kausikh
Kausikh offers a comprehensive portfolio of products and services, including Tablets, Capsules, Liquid Orals, Oral Suspension, and Sachet.
Solid dosage forms for administering medications
Gelatin shells containing powdered or liquid drugs
Solutions or suspensions for oral consumption
Liquid mixtures of drugs for easy ingestion
Powder packets for mixing with water or food
Antibiotic tablets targeting bacterial infections
Powder formulations that mix with water for syrup
Products combining nutrition and pharmaceuticals for health
Board of directors of Kausikh Therapeutics Private Limited (Kausikh)
Kausikh Therapeutics Private Limited is the primary company behind Kausikh. The board of Kausikh Therapeutics Private Limited currently have 3 directors; the longest-serving is Vaidhyanathen Neelakantan, appointed in 2000. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vaidhyanathen Neelakantan DIN 00899877 | Managing Director | 19 Apr 2000 | 26 yrs 6 mo | Kausikh Therapeutics Private Limited |
| Vaidhyanathan Ramasubrahmanian DIN 01036244 | Director | 19 Apr 2000 | 26 yrs 6 mo | Kausikh Therapeutics Private Limited |
| Anantharamkrishnan Vaidhyanathen DIN 01043244 | Director | 19 Apr 2000 | 26 yrs 6 mo | Kausikh Therapeutics Private Limited |
People of Kausikh
1 people are tracked at Kausikh (1 in leadership); the tracked headcount is 161.
| Name | Role | Group |
|---|---|---|
Kausic Neelakantan | Founder, Managing Director | Leadership |
Complete people profiles for Kausikh
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Kausikh
Figures of Kausikh Therapeutics Private Limited, the primary company behind Kausikh, for FY 2025. Revenue was ₹60.69 Cr (+8% year on year). Net profit was ₹53.3 Lakh (1% margin). EBITDA was ₹4.17 Cr (7% margin). Revenue has grown at a compounded annual rate of 0% over three years and +14% over five years.
- ₹60.69 CrRevenue · FY 2025 · +8% YoY
- ₹53.3 LakhNet profit · 1% margin
- ₹4.17 CrEBITDA · 7% margin
- ₹5.00 CrPaid-up capital
- 161Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kausikh Therapeutics Private Limited are on its company page.
Detailed financial statements for Kausikh
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Kausikh
Kausikh has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Kausikh
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kausikh
Kausikh was founded in 2000.
Kausikh is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Kausikh has 161 employees.
The primary company behind Kausikh, Kausikh Therapeutics Private Limited, reported revenue of βΉ60.69 Cr for FY 2025, up 8% year on year.
Kausikh Therapeutics, established in 2000, is a privately held company focused on producing pharmaceutical formulations in Chennai, India. It operates state-of-the-art plants adhering to cGMP guidelines, manufacturing a wide range of dosage forms like tablets and capsules. The company emphasizes contract research, customer-oriented manufacturing, and global market supply, serving clients with various product specifications and regulatory compliance.
Kausikh's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Kausikh offers Tablets, Capsules, Liquid Orals, Oral Suspension, and 4 more products and services.
Kausikh operates through Kausikh Therapeutics Private Limited.
The legal entities of Kausikh currently have 3 directors, including Vaidhyanathen Neelakantan, Vaidhyanathan Ramasubrahmanian, Anantharamkrishnan Vaidhyanathen.